US Stock MarketDetailed Quotes

GEMP Gemphire Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)

Gemphire Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.39%3.1M
-18.01%3.22M
-13.66%2.88M
-48.52%15.3M
-76.54%4.58M
13.20%3.46M
64.13%3.93M
-29.88%3.33M
47.28%29.72M
60.05%19.52M
Selling and administrative expenses
22.37%2.53M
16.88%2.24M
-10.61%1.96M
11.55%8.75M
48.68%2.58M
15.32%2.07M
11.41%1.91M
-15.79%2.19M
190.49%7.85M
225.43%1.74M
-General and administrative expense
22.37%2.53M
16.88%2.24M
-10.61%1.96M
11.55%8.75M
48.68%2.58M
15.32%2.07M
11.41%1.91M
-15.79%2.19M
190.49%7.85M
225.43%1.74M
Research and development costs
-59.04%571K
-51.19%982K
-19.51%920K
-70.07%6.55M
-88.77%2M
10.20%1.39M
198.52%2.01M
-46.89%1.14M
25.15%21.87M
30.95%17.78M
Operating profit
10.39%-3.1M
18.01%-3.22M
13.66%-2.88M
48.52%-15.3M
76.54%-4.58M
-13.20%-3.46M
-64.13%-3.93M
29.88%-3.33M
-47.28%-29.72M
-60.05%-19.52M
Net non-operating interest income expense
0
0
0
-64.10%14K
0
-50.00%3K
-37.50%5K
-70.00%6K
277.27%39K
126.32%5K
Non-operating interest income
--0
--0
--0
-64.10%14K
--0
--3K
--5K
--6K
--39K
----
Other net income (expense)
-9K
-84K
99.91%-1K
0
Other non- operating income (expenses)
---9K
---84K
----
----
----
----
----
----
---1K
--0
Income before tax
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
-13.33%-3.46M
-64.47%-3.92M
29.73%-3.32M
-39.25%-29.68M
-46.41%-19.51M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
-13.33%-3.46M
-64.47%-3.92M
29.73%-3.32M
-39.25%-29.68M
-46.41%-19.51M
Net income continuous Operations
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
-13.33%-3.46M
-64.47%-3.92M
29.73%-3.32M
-39.25%-29.68M
-46.41%-19.51M
Minority interest income
Net income attributable to the parent company
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
-13.33%-3.46M
-64.47%-3.92M
29.73%-3.32M
-39.25%-29.68M
-46.41%-19.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
-13.33%-3.46M
-64.47%-3.92M
29.73%-3.32M
-39.25%-29.68M
-46.41%-19.51M
Basic earnings per share
24.89%-3.5
33.33%-3.6
26.67%-3.3
63.93%-19.8
85.50%-5.22
18.25%-4.66
-20.00%-5.4
50.00%-4.5
55.15%-54.9
52.57%-36
Diluted earnings per share
24.89%-3.5
33.33%-3.6
26.67%-3.3
63.93%-19.8
85.50%-5.22
18.25%-4.66
-20.00%-5.4
50.00%-4.5
55.15%-54.9
52.57%-36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.39%3.1M-18.01%3.22M-13.66%2.88M-48.52%15.3M-76.54%4.58M13.20%3.46M64.13%3.93M-29.88%3.33M47.28%29.72M60.05%19.52M
Selling and administrative expenses 22.37%2.53M16.88%2.24M-10.61%1.96M11.55%8.75M48.68%2.58M15.32%2.07M11.41%1.91M-15.79%2.19M190.49%7.85M225.43%1.74M
-General and administrative expense 22.37%2.53M16.88%2.24M-10.61%1.96M11.55%8.75M48.68%2.58M15.32%2.07M11.41%1.91M-15.79%2.19M190.49%7.85M225.43%1.74M
Research and development costs -59.04%571K-51.19%982K-19.51%920K-70.07%6.55M-88.77%2M10.20%1.39M198.52%2.01M-46.89%1.14M25.15%21.87M30.95%17.78M
Operating profit 10.39%-3.1M18.01%-3.22M13.66%-2.88M48.52%-15.3M76.54%-4.58M-13.20%-3.46M-64.13%-3.93M29.88%-3.33M-47.28%-29.72M-60.05%-19.52M
Net non-operating interest income expense 000-64.10%14K0-50.00%3K-37.50%5K-70.00%6K277.27%39K126.32%5K
Non-operating interest income --0--0--0-64.10%14K--0--3K--5K--6K--39K----
Other net income (expense) -9K-84K99.91%-1K0
Other non- operating income (expenses) ---9K---84K---------------------------1K--0
Income before tax 10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M-13.33%-3.46M-64.47%-3.92M29.73%-3.32M-39.25%-29.68M-46.41%-19.51M
Income tax 0000000000
Net income 10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M-13.33%-3.46M-64.47%-3.92M29.73%-3.32M-39.25%-29.68M-46.41%-19.51M
Net income continuous Operations 10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M-13.33%-3.46M-64.47%-3.92M29.73%-3.32M-39.25%-29.68M-46.41%-19.51M
Minority interest income
Net income attributable to the parent company 10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M-13.33%-3.46M-64.47%-3.92M29.73%-3.32M-39.25%-29.68M-46.41%-19.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M-13.33%-3.46M-64.47%-3.92M29.73%-3.32M-39.25%-29.68M-46.41%-19.51M
Basic earnings per share 24.89%-3.533.33%-3.626.67%-3.363.93%-19.885.50%-5.2218.25%-4.66-20.00%-5.450.00%-4.555.15%-54.952.57%-36
Diluted earnings per share 24.89%-3.533.33%-3.626.67%-3.363.93%-19.885.50%-5.2218.25%-4.66-20.00%-5.450.00%-4.555.15%-54.952.57%-36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List